ondansetron has been researched along with dronabinol in 14 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 10 (71.43) | 29.6817 |
| 2010's | 4 (28.57) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Topliss, JG; Yoshida, F | 1 |
| Benz, RD; Contrera, JF; Kruhlak, NL; Matthews, EJ; Weaver, JL | 1 |
| Lombardo, F; Obach, RS; Waters, NJ | 1 |
| Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
| Alelyunas, YW; Bui, K; Empfield, JR; McCarthy, D; Pelosi-Kilby, L; Shen, C; Spreen, RC | 1 |
| Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
| Blumenstein, I; Schirrmacher, S; Stein, J | 1 |
| Burton, P; Kwiatkowska, M; Mechoulam, R; Parker, LA | 1 |
| Kwiatkowska, M; Parker, LA | 1 |
| Kwiatkowska, M; Mechoulam, R; Parker, LA | 1 |
| Hall, G; Limebeer, CL; Parker, LA | 1 |
| Baranowski, V; Barbato, LM; Carter, FJ; Jhangiani, H; Meiri, E; Vredenburgh, JJ; Yang, HM | 1 |
| Bilkei-Gorzo, A; Göthert, M; Markert, A; Rácz, I; Stamer, F; Zimmer, A | 1 |
| Bonner, N; Downey, R; Engeland, K; Jackson, M; Limebeer, CL; Morris, H; Navaratnam, R; Parker, LA; Rock, EM; Sticht, MA | 1 |
1 review(s) available for ondansetron and dronabinol
| Article | Year |
|---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
1 trial(s) available for ondansetron and dronabinol
| Article | Year |
|---|---|
Efficacy of dronabinol alone and in combination with ondansetron versus ondansetron alone for delayed chemotherapy-induced nausea and vomiting.
Topics: Adolescent; Adult; Analysis of Variance; Antineoplastic Combined Chemotherapy Protocols; Dose-Response Relationship, Drug; Double-Blind Method; Dronabinol; Drug Administration Schedule; Drug Therapy, Combination; Female; Follow-Up Studies; Humans; Male; Middle Aged; Nausea; Neoplasms; Ondansetron; Probability; Reference Values; Risk Assessment; Treatment Outcome; Vomiting | 2007 |
12 other study(ies) available for ondansetron and dronabinol
| Article | Year |
|---|---|
QSAR model for drug human oral bioavailability.
Topics: Administration, Oral; Biological Availability; Humans; Models, Biological; Models, Molecular; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Assessment of the health effects of chemicals in humans: II. Construction of an adverse effects database for QSAR modeling.
Topics: Adverse Drug Reaction Reporting Systems; Artificial Intelligence; Computers; Databases, Factual; Drug Prescriptions; Drug-Related Side Effects and Adverse Reactions; Endpoint Determination; Models, Molecular; Quantitative Structure-Activity Relationship; Software; United States; United States Food and Drug Administration | 2004 |
Trend analysis of a database of intravenous pharmacokinetic parameters in humans for 670 drug compounds.
Topics: Blood Proteins; Half-Life; Humans; Hydrogen Bonding; Infusions, Intravenous; Pharmacokinetics; Protein Binding | 2008 |
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Experimental solubility profiling of marketed CNS drugs, exploring solubility limit of CNS discovery candidate.
Topics: Central Nervous System Agents; Drug Evaluation, Preclinical; Hydrogen-Ion Concentration; Pharmaceutical Preparations; Solubility | 2010 |
[Pathogenesis and treatment of pruritus in patients with cholestasis].
Topics: Brain; Cholestasis; Cholestyramine Resin; Dronabinol; Enzyme Induction; Humans; Liver; Narcotic Antagonists; Ondansetron; Opioid Peptides; Phenobarbital; Pruritus; Rifampin; Skin; Synaptic Transmission; Treatment Outcome | 2003 |
A comparative analysis of the potential of cannabinoids and ondansetron to suppress cisplatin-induced emesis in the Suncus murinus (house musk shrew).
Topics: Animals; Antiemetics; Antineoplastic Agents; Cannabinoids; Cisplatin; Dose-Response Relationship, Drug; Dronabinol; Drug Therapy, Combination; Female; Lithium; Male; Ondansetron; Piperidines; Psychotropic Drugs; Pyrazoles; Rimonabant; Shrews; Vomiting | 2004 |
Ondansetron and Delta-9-tetrahydrocannabinol interfere with the establishment of lithium-induced conditioned taste avoidance in the house musk shrew (Suncus murinus).
Topics: Analgesics, Non-Narcotic; Analysis of Variance; Animals; Avoidance Learning; Behavior, Animal; Dose-Response Relationship, Drug; Dronabinol; Drug Interactions; Female; Lithium; Male; Ondansetron; Saccharin; Serotonin Antagonists; Shrews; Sweetening Agents; Taste; Vomiting | 2005 |
Delta-9-tetrahydrocannabinol and cannabidiol, but not ondansetron, interfere with conditioned retching reactions elicited by a lithium-paired context in Suncus murinus: An animal model of anticipatory nausea and vomiting.
Topics: Analysis of Variance; Animals; Antiemetics; Association Learning; Cannabidiol; Cannabinoids; Conditioning, Classical; Disease Models, Animal; Dronabinol; Female; Lithium Chloride; Male; Nausea; Ondansetron; Serotonin Antagonists; Shrews; Vomiting, Anticipatory | 2006 |
Exposure to a lithium-paired context elicits gaping in rats: A model of anticipatory nausea.
Topics: Animals; Antiemetics; Conditioning, Operant; Disease Models, Animal; Dronabinol; Infusions, Intravenous; Lithium; Male; Nausea; Ondansetron; Rats; Rats, Sprague-Dawley; Taste | 2006 |
Anandamide effects on 5-HT(3) receptors in vivo.
Topics: Analgesics, Opioid; Animals; Arachidonic Acids; Dronabinol; Endocannabinoids; Freezing Reaction, Cataleptic; Male; Mice; Mice, Knockout; Motor Activity; Ondansetron; Polyunsaturated Alkamides; Receptor, Cannabinoid, CB1; Receptor, Cannabinoid, CB2; Receptors, Serotonin, 5-HT3; Serotonin 5-HT3 Receptor Antagonists | 2008 |
A comparison of cannabidiolic acid with other treatments for anticipatory nausea using a rat model of contextually elicited conditioned gaping.
Topics: Animals; Anticipation, Psychological; Antiemetics; Cannabinoids; Chlordiazepoxide; Conditioning, Psychological; Dronabinol; Electroshock; Fear; Hypnotics and Sedatives; Lithium Chloride; Male; Motor Activity; Nausea; Ondansetron; Rats; Rats, Sprague-Dawley | 2014 |